Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients

Chest

Volumn 110, Issue 3, 1996, Pages 704-709

  Kshettry, Vibhu R ^a   Kroshus, Timothy J ^a   Savik, Kay ^a   Hertz, Marshall I ^a   Bolman III, R Morton ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

lung transplantation; obliterative bronchiolitis; primary pulmonary hypertension

Indexed keywords

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BRONCHIOLITIS; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HEART LUNG TRANSPLANTATION; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; VIRUS PNEUMONIA;

EID: 0030451240     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.3.704     Document Type: Article

References (18)

1. Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Transplant 1990; 9:593-601
2. Bolman RM, Shumway SJ, Estrin JA, et al. Lung and heart-lung transplantation: evolution and new applications. Ann Surg 1991; 214:456-70
3. Palevsky HI, Fishman AP. The management of primary pulmonary hypertension. JAMA 1991; 265:1014-20
4. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81
5. Rubin LJ, Peter RH. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med 1989; 302:69-73
6. Rich S, Brundage BH. High-dose calcium channel blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary artery pressure and recession of right ventricular hypertrophy. Circulation 1987; 76:135-41
7. D'Alonzo GE, Barst RJ, Avers SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective study. Ann Intern Med 1991; 115:343-49
8. McCarthy PM, Starnes VA, Theodore J, et al. Improved survival after heart-lung transplantation. J Thorac Cardiovasc Surg 1990; 99:54-60
9. Hutter JA, Scott JP, Deespins P, et al. Heart-lung transplantation at Papworth Hospital. Eur J Cardiothorac Surg 1989; 3:300-04
10. Reitz BA, Wallwork J, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982; 306:557-64
11. Pasque MK, Cooper JD, Kaiser LR, et al. Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg 1990; 49:785-91
12. Pasque MK, Kaiser LR, Dresler CM, et al. Single lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1992; 103:475-82
13. Burke CM, Morris AJ, Dawkins KD, et al. Late air flow obstruction in heart-lung transplant recipients. Heart Transplant 1985; 4:437-40
14. Theodore J, Starnes VA, Lewiston NJ. Obliterative bronchiolitis. Clin Chest Med 1990; 11:309-21
15. Burke CM, Theodare J, Baldwin JC, et al. Twenty-eight cases of human heart-lung transplantation. Lancet 1986; 1:517-19
16. Al-Dossari GA, Kshettry VR, Jessurun J, et al. Experimental large-animal model of obliterative bronchiolitis after lung transplantation. Ann Thorac Surg 1994; 58:34-40
17. Reinsmoen NL, Bolman RM, Savik K, et al. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection? Transplantation 1993; 55:1040-44
18. Reinsmoen NL, Bolman RM, Savik K, et al. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity. J Heart Lung Transplant 1994; 13:30-7